Dr. Vipul Kella, MD, MBA FACE, is a board-certified Emergency Medicine Physician and Health Care Consultant who advises hospital, health systems, and startup companies on clinical Best Practices and Policies.
As the founder of Insight, MD, LLC, Dr. Kella advises healthcare startups, hospitals, and health systems. His clients include venture capital startups, digital technology companies, telemedicine companies, medical-legal firms, and health systems.
Dr. Kella provides consulting services in the areas of:
Competitive Strategy and Intelligence - Clinical Best Practices - Medicolegal Issues - Medicolegal Risk
Dr. Kella is currently a Partner, clinician, and played a key role in the business growth of US Acute Care Solutions (USACS) while serving in hospital administrative and executive roles. He is recognized for clinical expertise, efficiency, innovation, and quality programs. Prior to his role at USACS, he served as the Hospital-Based Physician Chairman of Southern Maryland Hospital in Clinton MD. He was responsible for a turnaround of a distressed 65+k visit ER, and led numerous initiatives to improve staffing, quality, safety, and culture.
Dr. Kella is also an Investor and advisor for Global Health Impact Fund, a venture capital fund with a portfolio of early-stage healthcare technology companies.
View Dr. Vipul Kella's Expert Witness Profile.
The traditional definition of medical malpractice - medical care that falls below the accepted standards of care by “reasonable physicians” will now be scrutinized more than ever during and the years following the COVID19 pandemic. The pandemic placed enormous strain on our health systems: hospitals were operating at maximum capacity, supply shortages
Telehealth has been a boon in the COVID19 era. Patient populations that have once been difficult to treat or in rural areas now can receive medical care that was previously not accessible. This is especially important for patients with chronic diseases such as diabetes, kidney disease, COPD, and heart failure.
Recently, Feds have charged almost 350 people for submitting $6 billion in fraudulent claims. One of the largest initiatives, Operation Rubber Stamp, targeted a network of telemedicine fraud totaling over 4.5 billion in false claims. Operation Rupper stamp is the most-publicized action against telemedicine providers to date. A sting operation of this size adds a dose of reality and caution against telemedicine’s many benefits.
While the vaccines may potentially provide the widespread immunity needed to quell the spread of COVID19, questions remain about the medicolegal immunity medical providers will afford during and well after the pandemic.
